Trials / Completed
CompletedNCT02223650
A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
A Pilot Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Jaeb Center for Health Research · Academic / Other
- Sex
- All
- Age
- 3 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this short-term, pilot randomized trial comparing 2.50 diopters (D) overminus lens treatment vs. non-overminus (spectacles without overminus or no spectacles) in children with intermittent exotropia (IXT) 3 to \<7 years of age is to determine whether to proceed to a full-scale, longer-term randomized trial.
Detailed description
The objective of this short-term, pilot randomized trial comparing 2.50D overminus lens treatment vs. non-overminus (spectacles without overminus or no spectacles) is to determine whether to proceed to a full-scale, longer-term randomized trial. This decision will be based primarily on assessing the initial (8-week) response to overminus by comparing treatment groups on the following outcomes: * Mean distance IXT control score (each patient's score is the mean of 3 control scores) (primary outcome) * The proportion of subjects with treatment response, defined as 1 or more points improvement in mean of 3 distance IXT control scores (secondary outcome) * Adverse effects, near visual acuity outcomes, and spectacle wear compliance
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Overminus treatment | 2.50D overminus spectacles |
| DEVICE | Non-overminus treatment | spectacles without overminus or no spectacles |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-08-22
- Last updated
- 2017-05-19
- Results posted
- 2016-12-20
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02223650. Inclusion in this directory is not an endorsement.